This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

10 Pharma Stocks With 100% Buy Ratings

9. China Pharma Holdings (CPHI - Get Report), operating through its subsidiaries, manufactures drugs, including Chinese medicines. The company's products are used in the treatment of central nervous system disorders, cerebral and cardio vascular diseases, infectious, respiratory and digestive ailments.

Analysts polled by Bloomberg expect the company to report earnings per share of 16 cents 2010 fourth quarter, compared to 12 cents and 13 cents per share in the year-ago and quarter-ago periods, respectively. For the full year, the company is likely to report earnings per share of 52 cents for 2010, 56 cents for 2011 and 65 cents for 2012, against earnings of 48 cents per share for 2009.

The stock is currently trading at an attractive forward price-to-earnings multiple of 5.6, while Simcere Pharmaceutical Group (SCR), China-Biotics (CHBT) and American Oriental Bioengineering (AOB) are trading at PE multiples of 33.0, 8.9, and 9.0, respectively.

All the four analysts covering stock, recommend buying. Analysts polled by Bloomberg foresee the stock gaining around 106% over the next 12 months with a consensus target price of $5.8.
3 of 11

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
PATH $0.00 0.00%
ATHX $1.23 -0.81%
BDSI $3.73 -6.05%
CPHI $0.14 1.39%
MNOV $4.15 -3.26%


Chart of I:DJI
DOW 16,204.97 -211.61 -1.29%
S&P 500 1,880.05 -35.40 -1.85%
NASDAQ 4,363.1440 -146.4150 -3.25%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs